|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
IBC's Antimicrobial & Anti-Viral Drug Discovery | ||||||||||||||||
May 09, 2001 | ||||||||||||||||
IBC USA Conferences, Inc., Seaport Hotel * Boston, MA August 13-14, 2001 IBC's gathering of leading researchers in the field of Antimicrobial and Anti-Viral drug discovery will present their recent findings on: * Proven New Methods to Target Selections and Validations * Real-Time Assessment of Microbial Infections Using In vivo Biophotonic Imaging * Ground-Breaking Strategies to Treat HCV Infection * Genome Sequencing of Streptococcus Pyogenes - Potential Development of Novel Vaccines * Hear a Global Perspective on the Antibiotic Resistance Crisis from: Clifton E. Barry, III, Ph.D., Tuberculosis Research Section, NIH William H. Jarvis, M.D., Center for Disease Control & Prevention * Critical Updates on Cidecin, Ertapenem, Oritavancin, Anti-HIV Inhibitors, Zadaxin, and Influenza. |
||||||||||||||||
Organized by: | IBC USA Conferences, Inc. | |||||||||||||||
Deadline for Abstracts: | - | |||||||||||||||
Registration: | Five Easy Ways to Register! Phone (508) 616-5550 Fax (508) 616-5522 E-mail reg@ibcusa.com Online www.lifesciencesinfo.com/2647 Mail IBC USA Conferences, Inc. One Research Drive, Suite 400A Westborough, MA 01581-5195 |
|||||||||||||||
E-mail: | jprudhomme@ibcusa.com | |||||||||||||||
Posted by: | James G. Prudhomme | |||||||||||||||
Host: | 209.6.93.46 | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |